Artivion (AORT) Gains from Investment Securities (2017 - 2026)
Artivion's (AORT) quarterly Gains from Investment Securities came in at $1.7 million in Q1 2026, up 161.48% YoY from $665432.4 in Q1 2025, and down 67.23% on a QoQ basis from $5.3 million in Q4 2025.
Artivion (AORT) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Artivion (AORT) has 10 years of Gains from Investment Securities data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Gains from Investment Securities rose 161.48% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 million (up 237.47% YoY) and the FY2025 annual result came in at $7.7 million, up 169.94% from the prior year.
- Gains from Investment Securities slipped to $1.7 million in Q1 2026, from $5.3 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $10.9 million in Q2 2023 to a low of -$17.5 million in Q1 2024.
- A 5-year average of $758823.5 and a median of $1.7 million in 2026 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities soared 1450.0% — and 2024, when it tumbled 463.96%.
- Tracing AORT's Gains from Investment Securities over 5 years: stood at -$4.4 million in 2022, then surged by 136.14% to $1.6 million in 2023, then dropped by 27.04% to $1.2 million in 2024, then jumped by 357.76% to $5.3 million in 2025, then plunged by 67.23% to $1.7 million in 2026.
- The last three Gains from Investment Securities figures came in at $1.7 million (Q1 2026), $5.3 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Artivion | 1.37 Bn | 1.29 Bn | 80.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.00 Mn |
| Jun 30, 2026 | 8.00 Mn |
| Mar 31, 2026 | 1.74 Mn |
| Mar 31, 2026 | 1.74 Mn |
| Dec 31, 2025 | 5.31 Mn |
| Dec 31, 2025 | 5.31 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | -2.83 Mn |
| Mar 31, 2025 | -2.83 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | -17.47 Mn |
| Mar 31, 2024 | -17.47 Mn |